Zepbound is given once per week. It is stored in the refrigerator and does not need to be at room temperature before being injected. A best practice is to rotate injection sites each week.

The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for health insurers and ...

Expanding volumes of data point to mechanisms beyond weight loss and blood sugar control that contribute to cardiovascular ...

( NewsNation) — Zepbound became the first drug approved by the Food and Drug Administration to treat obstructive sleep apnea ...

The FDA removed Eli Lilly’s LLY tirzepatide injection products from the drug shortage list after determining that Lilly’s supply is currently meeting or exceeding demand and will continue to do so in ...

(NewsNation) — Zepbound became the first drug approved by the Food and Drug Administration to treat obstructive sleep apnea in obese adults earlier this month. “This is a major step forward ...

The FDA says side effects for Zepbound include nausea, diarrhea, vomiting, constipation, stomach pain, reactions at the injection site, fatigue, allergic reactions, burping, hair loss and ...

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).